Top

Child and Adolescent Psychiatry and Mental Health

Published in:

Open Access 01-12-2023 | Mood Disorders | Research

RETRACTED ARTICLE: Randomized controlled trial for selective preventive transdiagnostic intervention for adolescents at risk for emotional disorders

Authors: Manuel Vivas-Fernandez, Luis-Joaquin Garcia-Lopez, Jose A. Piqueras, Jose-Antonio Muela-Martinez, Josefa Canals-Sans, Lourdes Espinosa-Fernandez, David Jimenez-Vazquez, Maria del Mar Diaz-Castela, Paula Morales-Hidalgo, Maria Rivera, Jill Ehrenreich-May

Published in: Child and Adolescent Psychiatry and Mental Health | Issue 1/2023

Abstract

Significant evidence does exist on the effectiveness of transdiagnostic interventions to improve emotional problems in clinical populations, and their application as universal and indicated prevention programs. However, no randomized controlled trials (RCT) studying selective transdiagnostic prevention intervention have been published. This is the first known RCT to evaluate the efficacy/effectiveness of an evidence-based selective prevention transdiagnostic program for emotional problems in adolescents. The impact of three different interventions was evaluated: (1) PROCARE (Preventive transdiagnostic intervention for Adolescents at Risk for Emotional disorders), which is a group-based, online-delivered, abbreviated version of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Adolescents (UP-A), along with adding a booster session, to reduce risk of onset of anxiety and depression, (2) PROCARE + , which includes the PROCARE protocol along with personalized add-on modules tailored to match adolescents’ risk factors, and (3) an active control condition (ACC) based on emotional psychoeducation. In total, 286 adolescents (53.3% girls) evidencing high risk and low protective factors were randomized and allocated to PROCARE, PROCARE + or ACC. Self- and parent-reported measures were taken at baseline, as well as after the intervention, a 6-month follow-up was carried out, together with a 1-month follow-up after the booster session. Differences between conditions were significant on most of the outcome measures, with superior effect sizes for PROCARE +. Interventions were excellent in terms of acceptability, with good satisfaction rates. Tailored selective transdiagnostic interventions focused on mitigating risk factors and promoting protective factors in vulnerable adolescents are promising.

Ahola P, Joensuu M, Knekt P, Lindfors O, Saarinen P, Tolmunen T, Lehtonen J. Effects of scheduled waiting for psychotherapy in patients with major depression. J Nerv Ment Dis. 2017;205(8):611–7. https://doi.org/10.1097/NMD.0000000000000616.CrossRefPubMed

Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The fear of COVID-19 scale: development and initial validation. Int J Mental Health Addiction. 2020. https://doi.org/10.1007/s11469-020-00270-8.CrossRef

Alonso J Liu Z, Evans-Lacko S, Sadikova E, Sampson N, Chatterji S, Abdulmalik J, Aguilar-Gaxiola S, Al-Hamzawi A, Andrade LH, Bruffaerts R, Cardoso G, Cia, A., Florescu S, de Girolamo G, Gureje O, Haro J. M., He Y, de Jonge P, Karam, EG WHO World Mental Health Survey Collaborators. Treatment gap for anxiety disorders is global: results of the World Mental Health surveys in 21 countries. Depress Anxiety. 2018;35(3):195–208. https://doi.org/10.1002/da.22711.CrossRef

Joint Task Force for the Development of Telepsychology Guidelines for Psychologists. Guidelines for the practice of telepsychology. American Psychologist. 2013;68(9):791–800. https://doi.org/10.1037/a0035001.

Anniko MK, Boersma K, Tillfors M. Sources of stress and worry in the development of stress-related mental health problems: a longitudinal investigation from early—to mid-adolescence. Anxiety Stress Coping. 2019;32(2):155–67. https://doi.org/10.1080/10615806.2018.1549657.CrossRefPubMed

Axelson DA, Birmaher B. Relation between anxiety and depressive disorders in childhood and adolescence. Depress Anxiety. 2001;14(2):67–78. https://doi.org/10.1002/da.1048.CrossRefPubMed

Balázs J, Miklósi M, Keresztény Á, Hoven CW, Carli V, Wasserman C, Wasserman D. Adolescent subthreshold-depression and anxiety: psychopathology, functional impairment and increased suicide risk. J Child Psychol Psychiatry. 2013;54(6):670–7. https://doi.org/10.1111/jcpp.12016.CrossRefPubMed

Barlow DH, Allen LB, Choate ML. Toward a unified treatment for emotional disorders—republished article. Behav Ther. 2016;47(6):838–53. https://doi.org/10.1016/j.beth.2016.11.005.CrossRefPubMed

Barriuso-Lapresa LM, Hernando-Arizaleta L, Rajmil L. Reference values of the strengths and difficulties questionnaire (SDQ) version for parents in the Spanish population, 2006. Actas Esp Psiquiatr. 2014;42(2):43–8.PubMed

10.

Beesdo K, Knappe S, Pine DS. Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V. Psychiatric Clinics. 2009;32(3):483–524. https://doi.org/10.1016/j.psc.2009.06.002.CrossRefPubMed

11.

Bennett K, Manassis K, Duda S, Bagnell A, Bernstein GA, Garland EJ, Miller LD, Newton A, Thabane L, Wilansky P. Preventing child and adolescent anxiety disorders: overview of systematic reviews. Depress Anxiety. 2015;32(12):909–18. https://doi.org/10.1002/da.22400.CrossRefPubMed

12.

Bolinski F, Kleiboer A, Karyotaki E, Bosmans JE, Zarski AC, Weisel KK, Riper H. Effectiveness of a transdiagnostic individually tailored Internet-based and mobile-supported intervention for the indicated prevention of depression and anxiety (ICare Prevent) in Dutch college students: study protocol for a randomised controlled trial. Trials. 2018;19(1):1–13. https://doi.org/10.1186/s13063-018-2477-y.CrossRef

13.

Bouter DC, Zarchev M, de Neve-Enthoven N, Ravensbergen SJ, Kamperman AM, Hoogendijk W, Grootendorst-van Mil NH. A longitudinal study of mental health in at-risk adolescents before and during the COVID-19 pandemic. Eur Child Adolesc Psychiatry. 2022. https://doi.org/10.1007/s00787-021-01935-y

14.

Brunwasser SM, Gillham JE, Kim ES. A meta-analytic review of the penn resiliency program’s effect on depressive symptoms. J Consult Clin Psychol. 2009;77(6):1042–54. https://doi.org/10.1037/a0017671.CrossRefPubMedPubMedCentral

15.

Caldas JM. European framework for action on mental health and wellbeing final conference. EU Joint action on mental health and well being, Brussells, Belgium. 2016. https://ec.europa.eu/research/participants/data/ref/h2020/other/guides_for_applicants/h2020-SC1-BHC-22-2019-framework-for-action_en.pdf. Accesed 5 Jan 2023.

16.

Calear AL, Christensen H, Mackinnon A, Griffiths KM, O’Kearney R. The youthmood project: a cluster randomized controlled trial of an online cognitive behavioral program with adolescents. J Consult Clin Psychol. 2009;77(6):1021–32. https://doi.org/10.1037/a0017391.CrossRefPubMed

17.

Campbell-Sills L, Stein MB. Psychometric analysis and refinement of the connor-davidson resilience scale (CD-RISC): validation of a 10-item measure of resilience. J Trauma Stress. 2007;20(6):1019–28. https://doi.org/10.1002/jts.20271.CrossRefPubMed

18.

Chorpita BF, Yim L, Moffitt C, Umemoto LA, Francis SE. Assessment of symptoms of DSM-IV anxiety and depression in children: a revised child anxiety and depression scale. Behav Res Ther. 2000;38(8):835–55. https://doi.org/10.1016/s0005-7967(99)00130-8.CrossRefPubMed

19.

Clarke GN, Hawkins W, Murphy M, Sheeber LB, Lewinsohn PM, Seeley JR. Targeted prevention of unipolar depressive disorder in an at-risk sample of high school adolescents: a randomized trial of a group cognitive intervention. J Am Acad Child Adolesc Psychiatry. 1995;34(3):312–21. https://doi.org/10.1097/00004583-199503000-00016.CrossRefPubMed

20.

Clarke GN, Hornbrook M, Lynch F, Polen M, Gale J, Beardslee W, O’Connor E, Seeley J. A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents. Arch Gen Psychiatry. 2001;58(12):1127–34. https://doi.org/10.1001/archpsyc.58.12.1127.CrossRefPubMed

21.

Cobos-Sánchez L, Flujas-Contreras JM, Gómez I. Willingness and action measure for adolescents: Psychometric validation in Spanish adolescents. J Contextual Behav Sci. 2020;15:46–51. https://doi.org/10.1016/j.jcbs.2019.11.006.CrossRef

22.

Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Erlbaum Associates, Publishers; 1988.

23.

Connor KM, Davidson JR. Development of a new resilience scale: the connor-davidson resilience Scale (CD-RISC). Depress Anxiety. 2003;18(2):76–82. https://doi.org/10.1002/da.10113.CrossRefPubMed

24.

Copeland WE, Shanahan L, Costello EJ, Angold A. Childhood and adolescent psychiatric disorders as predictors of young adult disorders. Arch Gen Psychiatry. 2009;66(7):764–72. https://doi.org/10.1001/archgenpsychiatry.2009.85.CrossRefPubMedPubMedCentral

25.

Cunningham JA, Kypri K, McCambridge J. Exploratory randomized controlled trial evaluating the impact of a waiting list control design. BMC Med Res Methodol. 2013;13:150. https://doi.org/10.1186/1471-2288-13-150.CrossRefPubMedPubMedCentral

26.

Ehrenreich-May J, Kennedy SM, Sherman JA, Bilek EL, Buzzella BA, Bennett SM, Barlow DH. The unified protocol for transdiagnostic treatment of emotional disorders in adolescents (UP-A; in Unified protocols for transdiagnostic treatment of emotional disorders in children and adolescents). New York: Oxford University Press; 2018.

27.

Ehrenreich-May J, Kennedy SM, editors. Applications of the unified protocols for transdiagnostic treatment of emotional disorders in children and adolescents. New York: Oxford University Press; 2021.

28.

Erskine HE, Moffitt TE, Copeland WE, Costello EJ, Ferrari AJ, Patton G, Degenhardt L, Vos T, Whiteford HA, Scott JG. A heavy burden on young minds: the global burden of mental and substance use disorders in children and youth. Psychol Med. 2015;45(7):1551–63. https://doi.org/10.1017/S0033291714002888.CrossRefPubMed

29.

Fegert JM, Vitiello B, Plener PL, Clemens V. Challenges and burden of the Coronavirus 2019 (COVID-19) pandemic for child and adolescent mental health: a narrative review to highlight clinical and research needs in the acute phase and the long return to normality. Child Adol Psychiatry Mental Health. 2020. https://doi.org/10.1186/s13034-020-00329-3.CrossRef

30.

Feiss R, Dolinger SB, Merritt M, Reiche E, Martin K, Yanes JA, Thomas CM, Pangelinan M. A systematic review and meta-analysis of school-based stress, anxiety, and depression prevention programs for adolescents. J Youth Adolesc. 2019;48(9):1668–85. https://doi.org/10.1007/s10964-019-01085-0.CrossRefPubMedPubMedCentral

31.

Fisak BJ Jr, Richard D, Mann A. The prevention of child and adolescent anxiety: a meta-analytic review. Prevention Sci. 2011;12(3):255–68. https://doi.org/10.1007/s11121-011-0210-0.CrossRef

32.

Fonseca Pedrero E, Pérez Álvarez M, Al-Halabí Díaz S, Inchausti Gómez F, López Navarro E, Muñiz Fernández J, Montoya Castilla I. Tratamientos psicológicos empíricamente apoyados para la infancia y adolescencia: estado de la cuestión. Psicothema. 2021;33(3):386–98. https://doi.org/10.7334/psicothema2021.56.CrossRefPubMed

33.

Furukawa TA, Noma H, Caldwell DM, Honyashiki M, Shinohara K, Imai H, Chen P, Hunot V, Churchill R. Waiting list may be a nocebo condition in psychotherapy trials: a contribution from network meta-analysis. Acta Psychiatr Scand. 2014;130(3):181–92. https://doi.org/10.1111/acps.12275.CrossRefPubMed

34.

Gálvez Casas A, Rosa Guillamón A, García-Cantó E, Rodríguez García PL, Pérez-Soto JJ, Tarraga Marcos L, Tarraga López P. Estado nutricional y calidad de vida relacionada con la salud en escolares del sureste español. Nutr Hosp. 2014;31(2):737–43. https://doi.org/10.3305/nh.2015.31.2.8468.CrossRefPubMed

35.

Garaigordobil M. Cyberbullying: screening de acoso entre iguales. Madrid, TEA Ediciones: 2013.

36.

Garaigordobil M. Cyberbullying screening de acoso entre iguales: descripción y datos psicométricos. Int J Dev Educ Psychol. 2014. https://doi.org/10.7060/ijodaep.2014.n1.v4.617.CrossRef

37.

Garber J. Depression in children and adolescents: linking risk research and prevention. Am J Prev Med. 2006;31(6 Suppl 1):S104–25. https://doi.org/10.1016/j.amepre.2006.07.007.CrossRefPubMed

38.

Garber J, Weersing VR. Comorbidity of anxiety and depression in youth: implications for treatment and prevention. Clin Psychol. 2010;17(4):293–306. https://doi.org/10.1111/j.1468-2850.2010.01221.x.CrossRef

39.

García-Escalera J, Chorot P, Sandín B, Ehrenreich-May J, Prieto A, Valiente RM. An open trial applying the unified protocol for transdiagnostic treatment of emotional disorders in adolescents (UP-A) adapted as a school-based prevention program. Child Youth Care Forum. 2019;48(1), 29–53. https://doi.org/10.1007/s10566-018-9471-0.CrossRef

40.

García-Lopez LJ. Impact of pandemic and aftermath on resilience of young people in the era of Coronavirus. In: Grande-Gascón ML, de Faramiñán JM, editors. Impact of Covid-19 in Jaen analyses and recommendations. Jaen: Institute of advanced studies; 2022.

41.

Gearing RE, Schwalbe CSJ, Lee R, Hoagwood KE. The effectiveness of booster sessions in CBT treatment for child and adolescent mood and anxiety disorders. Depress Anxiety. 2013;30(9):800–8. https://doi.org/10.1002/da.22118.CrossRefPubMed

42.

Ghandour RM, Sherman LJ, Vladutiu CJ, Ali MM, Lynch SE, Bitsko RH, Blumberg SJ. Prevalence and treatment of depression, anxiety, and conduct problems in US children. J Pediatr. 2019;206:256–67. https://doi.org/10.1016/j.jpeds.2018.09.021.CrossRefPubMed

43.

González-Carrasco M, Casas F, Malo S, Viñas F, Dinisman T. Changes with age in subjective well-being through the adolescent years: differences by gender. J Happiness Stud. 2017;18(1):63–88. https://doi.org/10.1007/s10902-016-9717-1.CrossRef

44.

Goodman R. The strengths and difficulties questionnaire: a research note. J Child Psychol Psychiatry. 1997;38(5):581–6. https://doi.org/10.1111/j.1469-7610.1997.tb01545.x.CrossRefPubMed

45.

Goodman R, Ford T, Simmons H, Gatward R, Meltzer H. Using the strengths and difficulties questionnaire (SDQ) to screen for child psychiatric disorders in a community sample. British J Psychiatry. 2000;177:534–9. https://doi.org/10.1192/bjp.177.6.534.CrossRef

46.

Gratz KL, Roemer L. Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scale. J Psychopathol Behav Assess. 2004;26(1):41–54. https://doi.org/10.1023/B:JOBA.0000007455.08539.94.CrossRef

47.

Greco LA, Murrell AM, Coyne LW. Willingness and acceptance measure for children and adolescents (WAM-C/A). 2004. https://contextualscience.org/. Accesed 5 Jan 2023.

48.

Guessoum SB, Lachal J, Radjack R, Carretier E, Minassian S, Benoit L, Moro MR. Adolescent psychiatric disorders during the COVID-19 pandemic and lockdown. Psychiatry Res. 2020. https://doi.org/10.1016/j.psychres.2020.113264.CrossRefPubMedPubMedCentral

49.

Herrero R, Mira A, Cormo G, Etchemendy E, Baños R, García-Palacios A, Ebert DD, Franke M, Berger T, Schaub MP, Görlich D, Jacobi C, Botella C. An internet based intervention for improving resilience and coping strategies in university students: study protocol for a randomized controlled trial. Internet Interv. 2019;16:43–51. https://doi.org/10.1016/j.invent.2018.03.005.CrossRefPubMed

50.

Hervás G, Jódar R. Adaptación al castellano de la Escala de dificultades en la regulación emocional. Clin salud. 2008;19(2):139–56.

51.

Hugh-Jones S, Beckett S, Tumelty E, Mallikarjun P. Indicated prevention interventions for anxiety in children and adolescents: a review and meta-analysis of school-based programs. Eur Child Adolesc Psychiatry. 2021;30(6):849–60. https://doi.org/10.1007/s00787-020-01564-x.CrossRefPubMed

52.

IBM Corp. Released. IBM SPSS Statistics for windows, version 28.0. Armonk, NY: IBM corp IBM SPSS statistics 28.0 (IBM corp released, 2021): 2021.

53.

James AC, Reardon T, Soler A, James G, Creswell C. Cognitive behavioral therapy for anxiety disorders in children and adolescents. Cochrane Database Sys Rev. 2020. https://doi.org/10.1002/14651858.CD013162.pub2.CrossRef

54.

Jané-Llopis E, Hosman C, Jenkins R, Anderson P. Predictors of efficacy in depression prevention programmes. meta-analysis. British J Psychiatry J Mental Sci. 2003;183:384–97. https://doi.org/10.1192/bjp.183.5.384.CrossRef

55.

Jaycox LH, Stein BD, Paddock S, Miles JN, Chandra A, Meredith LS, Tanielian T, Hickey S, Burnam MA. Impact of teen depression on academic, social, and physical functioning. Pediatrics. 2009;124(4):e596–605. https://doi.org/10.1542/peds.2008-3348.CrossRefPubMed

56.

Kishida K, Hida N, Ishikawa SI. Evaluating the effectiveness of a transdiagnostic universal prevention program for both internalizing and externalizing problems in children: two feasibility studies. Child Adolesc Psychiatry Ment Health. 2022;16(1):1–10. https://doi.org/10.1186/s13034-022-00445-2.CrossRef

57.

La Greca AM, Ehrenreich-May J, Mufson L, Chan S. Preventing adolescent social anxiety and depression and reducing peer victimization: intervention development and open trial. Child Youth Care Forum. 2016;45(6):905–26. https://doi.org/10.1007/s10566-016-9363-0.CrossRefPubMedPubMedCentral

58.

Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2(3):197–207. https://doi.org/10.1016/0149-7189(79)90094-6.CrossRefPubMed

59.

Larson CM. Stories: a revision of the willingness & action measure for children and adolescents (WAM-C/A). University of North Texas. 2008. https://digital.library.unt.edu/ark:/67531/metadc9761/m2/1/high_res_d/thesis.pdf. Accesed 5 Jan 2023.

60.

Lawrence PJ, Rooke SM, Creswell C. Review: prevention of anxiety among at-risk children and adolescents—a systematic review and meta-analysis. Child Adolesc Mental Health. 2017;22(3):118–30. https://doi.org/10.1111/camh.12226.CrossRef

61.

Loewen OK, Maximova K, Ekwaru JP, Faught EL, Asbridge M, Ohinmaa A, Veugelers PJ. Lifestyle behavior and mental health in early adolescence. Pediatrics. 2019;143(5):11. https://doi.org/10.1542/peds.2018-3307.CrossRef

62.

Løvaas MES, Lydersen S, Sund AM, Neumer SP, Martinsen KD, Holen S, Reinfjell T. A 12-month follow-up of a transdiagnostic indicated prevention of internalizing symptoms in school-aged children: the results from the EMOTION study. Child Adolesc Psychiatry Ment Health. 2020;14(1):1–13. https://doi.org/10.1186/s13034-020-00322-w.CrossRef

63.

Merikangas KR, He JP, Brody D, Fisher PW, Bourdon K, Koretz DS. Prevalence and treatment of mental disorders among US children in the 2001–2004 NHANES. Pediatrics. 2010;125(1):75–81. https://doi.org/10.1542/peds.2008-2598.CrossRefPubMed

64.

Merikangas KR, He JP, Burstein M, Swendsen J, Avenevoli S, Case B, Georgiades K, Heaton L, Swanson S, Olfson M. Service utilization for lifetime mental disorders in U.S. adolescents: results of the national comorbidity survey-adolescent supplement (NCS-A). J Ame Acad Child Adol Psychiatry. 2011;50(1):32–45. https://doi.org/10.1016/j.jaac.2010.10.006.CrossRef

65.

Merry SN, Hetrick SE, Cox GR, Brudevold-Iversen T, Bir JJ, McDowell H. Psychological and educational interventions for preventing depression in children and adolescents. Cochrane Database of Sys Rev. 2011. https://doi.org/10.1002/14651858.CD003380.pub3.CrossRef

66.

Merry SN, Hetrick SE, Cox GR, Brudevold-Iversen T, Bir JJ, McDowell H. Cochrane review: psychological and educational interventions for preventing depression in children and adolescents. Evidence Based Child Health Cochrane Rev J. 2012;7(5):1409–685. https://doi.org/10.1002/ebch.1867.CrossRef

67.

Mettert K, Lewis C, Dorsey C, Halko H, Weiner B. Measuring implementation outcomes: an updated systematic review of measures psychometric properties. Implement Res Prac. 2020. https://doi.org/10.1177/2633489520936644.CrossRef

68.

Muela-Martinez JA, Espinosa-Fernandez L, Garcia-Lopez LJ, Martin-Puga ME. Validation of the structured interview for the assessment of expressed emotion (E5) in a sample of adolescents and young adults from the general population. Front Psychol. 2021. https://doi.org/10.3389/fpsyg.2021.723323.CrossRefPubMedPubMedCentral

69.

Munder T, Flückiger C, Leichsenring F, Abbass AA, Hilsenroth MJ, Luyten P, Wampold BE. Is psychotherapy effective? a re-analysis of treatments for depression. Epidemiol Psychiatric Sci. 2019;28(3):268–74. https://doi.org/10.1017/S2045796018000355.CrossRef

70.

Notario-Pacheco B, Solera-Martínez M, Serrano-Parra MD, Bartolomé-Gutiérrez R, García-Campayo J, Martínez-Vizcaíno V. Reliability and validity of the spanish version of the 10-item connor-davidson resilience scale (10-item CD-RISC) in young adults. Health Qual Life Outcomes. 2011;9:63. https://doi.org/10.1186/1477-7525-9-63.CrossRefPubMedPubMedCentral

71.

Ortuño-Sierra J, Fonseca-Pedrero E, Paíno M, Aritio-Solana R. Prevalence of emotional and behavioral symptomatology in Spanish adolescents. Rev Psiquiatr Salud Ment. 2014;7(3):121–30. https://doi.org/10.1016/j.rpsm.2013.12.003.CrossRefPubMed

72.

Pachankis JE. A transdiagnostic minority stress treatment approach for gay and bisexual men’s syndemic health conditions. Arch Sex Behav. 2015;44(7):1843–60. https://doi.org/10.1007/s10508-015-0480-x.CrossRefPubMedPubMedCentral

73.

Piqueras JA, Gomez-Gomez M, Marzo JC, Gomez-Mir P, Falco R, Valenzuela B, PSICORECUR-SOS COVID-19 Studygroup. Correction to: Validation of the Spanish Version of Fear of COVID-19 Scale: its association with acute stress and coping. Int J Mental Health Addict. 2021. https://doi.org/10.1007/s11469-021-00703-y.CrossRef

74.

Piqueras JA, Pineda D, Martin-Vivar M, Sandín B. Confirmatory factor analysis and psychometric properties of the revised child anxiety and depression scale−30 (RCADS-30) in clinical and non-clinical samples. Rev. de Psicopatol. y Psicol. Clin. 2017;22(3):183–96. https://doi.org/10.5944/rppc.vol.22.num.3.2017.19332.CrossRef

75.

Polanczyk GV, Salum GA, Sugaya LS, Caye A, Rohde LA. Annual research review: a meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry. 2015;56(3):345–65. https://doi.org/10.1111/jcpp.12381.CrossRefPubMed

76.

Power E, Hughes S, Cotter D, Cannon M. Youth mental health in the time of COVID-19. Irish J Psychol Med. 2020;37(4):301–5. https://doi.org/10.1017/ipm.2020.84.CrossRef

77.

Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, Griffey R, Hensley M. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65–76. https://doi.org/10.5944/rppc.vol.15.num.3.2010.4095.CrossRefPubMed

78.

Racine N, McArthur BA, Cooke JE, Eirich R, Zhu J, Madigan S. Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: a meta-analysis. JAMA Pediatr. 2021;175(11):1142–50. https://doi.org/10.1001/jamapediatrics.2021.2482.CrossRefPubMed

79.

Rasing S, Creemers D, Janssens J, Scholte R. Depression and anxiety prevention based on cognitive behavioral therapy for at-risk adolescents: a meta-analytic review. Front Psychol. 2017;8:1066. https://doi.org/10.3389/fpsyg.2017.01066.CrossRefPubMedPubMedCentral

80.

Ravens-Sieberer U, Erhart M, Rajmil L, Herdman M, Auquier P, Bruil J, Kilroe J. Reliability, construct and criterion validity of the KIDSCREEN-10 score: a short measure for children and adolescents’ well-being and health-related quality of life. Qual Life Res. 2010;19(10):1487–500. https://doi.org/10.1007/s11136-010-9706-5.CrossRefPubMedPubMedCentral

81.

Ravens-Sieberer U, Gosch A, Abel T, Auquier P, Bellach BM, Bruil J, Rajmil L. Quality of life in children and adolescents: a European public health perspective. Soz Praventiv Med. 2001;46(5):294–302. https://doi.org/10.1007/BF01321080.CrossRef

82.

Reef J, Diamantopoulou S, van Meurs I, Verhulst F, van der Ende J. Child to adult continuities of psychopathology: a 24-year follow-up. Acta Psychiatr Scand. 2009;120(3):230–8. https://doi.org/10.1111/j.1600-0447.2009.01422.x.CrossRefPubMed

83.

Sandín B, Valiente RM, Chorot P. RCADS: evaluación de los síntomas de los trastornos de ansiedad y depresión en niños y adolescentes. Rev. de Psicopatol. y Psicol. Clin. 2009;14(3):193–206. https://doi.org/10.5944/rppc.vol.14.num.3.2009.4078.CrossRef

84.

Sandín B, Chorot P, Valiente RM, Chorpita BF. Desarrollo de una versión de 30 items de la revised child anxiety and depression scale. Rev. de Psicopatol. y Psicol. Clin. 2010;15(3):165–78. https://doi.org/10.5944/rppc.vol.15.num.3.2010.4095.CrossRef

85.

Sandín B, Chorot P, Valiente RM. Transdiagnóstico: Nueva frontera en psicología clínica. Rev de Psicopatol y Psicol Clin. 2012;17:185–203. https://doi.org/10.5944/rppc.vol.17.num.3.2012.11839.CrossRef

86.

Santomauro DF, Mantilla-Herrera AM, Shadid J, Zheng P, Ashbaugh C, Pigott DM, Abbafati C, Adolph C, Amlag JO, Aravkin AY, Bang-Jensen BL, Gregory J, Bertolacci GJ, Bloom SS, Castellano R, Castro E, Chakrabarti S, Chattopadhyay J, Cogen RM, Collins JK, Dai X. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398(10312):1700–12. https://doi.org/10.1016/S0140-6736(21)02143-7.CrossRef

87.

Sauer-Zavala S, Tirpak JW, Eustis EH, Woods BK, Russell K. Unified protocol for the transdiagnostic prevention of emotional disorders: evaluation of a brief, online course for college freshmen. Behav Ther. 2021;52(1):64–76. https://doi.org/10.1016/j.beth.2020.01.010.CrossRefPubMed

88.

Schmitt JC, Valiente RM, García-Escalera J, Arnáez S, Espinosa V, Sandín B, Chorot P. Prevention of depression and anxiety in subclinical adolescents: effects of a transdiagnostic internet-delivered CBT program. Int J Environ Res Public Health. 2022;19(9):5365. https://doi.org/10.3390/ijerph19095365.CrossRefPubMedPubMedCentral

89.

Seeley JR, Stice E, Rohde P. Screening for depression prevention: identifying adolescent girls at high risk for future depression. J Abnorm Psychol. 2009;118(1):161–70. https://doi.org/10.1037/a0014741.CrossRefPubMedPubMedCentral

90.

Solmi M, Radua J, Olivola M, Croce E, Soardo L, Salazar de Pablo G, Fusar-Poli P. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol Psychiatry. 2021. https://doi.org/10.1038/s41380-021-01161-7.CrossRefPubMedPubMedCentral

91.

Stice E, Shaw H, Bohon C, Marti CN, Rohde P. A meta-analytic review of depression prevention programs for children and adolescents: factors that predict magnitude of intervention effects. J Consult Clin Psychol. 2009;77(3):486–503. https://doi.org/10.1037/a0015168.CrossRefPubMedPubMedCentral

92.

Stockings EA, Degenhardt L, Dobbins T, Lee YY, Erskine HE, Whiteford HA, Patton G. Preventing depression and anxiety in young people: a review of the joint efficacy of universal, selective and indicated prevention. Psychol Med. 2016;46(1):11–26. https://doi.org/10.1017/S0033291715001725.CrossRefPubMed

93.

Stone LL, Otten R, Engels RC, Vermulst AA, Janssens JM. Psychometric properties of the parent and teacher versions of the strengths and difficulties questionnaire for 4–12-year-olds: a review. Clin Child Fam Psychol Rev. 2010;13(3):254–74. https://doi.org/10.1007/s10567-010-0071-2.CrossRefPubMedPubMedCentral

94.

Teubert D, Pinquart M. A meta-analytic review on the prevention of symptoms of anxiety in children and adolescents. J Anxiety Disord. 2011;25(8):1046–59. https://doi.org/10.1016/j.janxdis.2011.07.001.CrossRef

95.

Van Balkom AJ, van Boeijen CA, Boeke AJ, van Oppen P, Kempe PT, van Dyck R. Comorbid depression, but not comorbid anxiety disorders, predicts poor outcome in anxiety disorders. Depress Anxiety. 2008;25(5):408–15. https://doi.org/10.1002/da.20386.CrossRefPubMed

96.

Vázquez FL, Torres A, Otero P, Blanco V, Attkisson CC. Psychometric properties of the castilian spanish version of the client satisfaction questionnaire (CSQ-8). Curr Psychol. 2019;2019(38):829–35. https://doi.org/10.1007/s12144-017-9659-8.CrossRef

97.

Verboom CE, Sijtsema JJ, Verhulst FC, Penninx BW, Ormel J. Longitudinal associations between depressive problems, academic performance, and social functioning in adolescent boys and girls. Dev Psychol. 2014;50(1):247–57. https://doi.org/10.1037/a0032547.CrossRefPubMed

98.

Voltas N, Hernández-Martínez C, Arija V, Canals J. Suicidality in a community sample of early adolescents: a three-phase follow-up study. Archives Suic Res. 2020;24(sup2):S217–35. https://doi.org/10.1080/13811118.2019.1588816.CrossRef

99.

Weisel KK, Zarski AC, Berger T, Krieger T, Schaub MP, Moser CT, Ebert DD. Efficacy and cost-effectiveness of guided and unguided internet-and mobile-based indicated transdiagnostic prevention of depression and anxiety (ICare prevent): a three-armed randomized controlled trial in four European countries. Internet Interv. 2019;16:52–64. https://doi.org/10.1016/j.invent.2018.04.002.CrossRefPubMed

100.

Weitkamp K, Seiffge-Krenke I. The association between parental rearing dimensions and adolescent psychopathology: a cross-cultural study. J Youth Adolesc. 2019;48(3):469–83. https://doi.org/10.1007/s10964-018-0928-0.CrossRefPubMed

101.

Werner-Seidler A, Perry Y, Calear AL, Newby JM, Christensen H. School-based depression and anxiety prevention programs for young people: A systematic review and meta-analysis. Clin Psychol Rev. 2017;51:30–47. https://doi.org/10.1016/j.cpr.2016.10.005.CrossRefPubMed

102.

Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Vos T. Global burden of disease attributable to mental and substance use disorders: findings from the Global burden of disease study 2010. Lancet. 2013;382(9904):1575–86. https://doi.org/10.1016/S0140-6736(13)61611-6.CrossRefPubMed

103.

Wilamowska ZA, Thompson-Hollands J, Fairholme CP, Ellard KK, Farchione TJ, Barlow DH. Conceptual background, development, and preliminary data from the unified protocol for transdiagnostic treatment of emotional disorders. Depress Anxiety. 2010;27(10):882–90. https://doi.org/10.1002/da.20735.CrossRefPubMed

104.

Wierzbicki M, Pekarik G. A meta-analysis of psychotherapy dropout. Prof Psychol Res Pract. 1993;24(2):190. https://doi.org/10.1037/0735-7028.24.2.190.CrossRef

105.

World Health Organization (WHO). mhGAP Intervention Guide—Version 2 0. Geneve: WHO Press; 2016.

106.

World Health Organization (WHO). Depression 2021 https://www.who.int/news-room/fact-sheets/detail/depression.

Title: RETRACTED ARTICLE: Randomized controlled trial for selective preventive transdiagnostic intervention for adolescents at risk for emotional disorders
Authors: Manuel Vivas-Fernandez
Luis-Joaquin Garcia-Lopez
Jose A. Piqueras
Jose-Antonio Muela-Martinez
Josefa Canals-Sans
Lourdes Espinosa-Fernandez
David Jimenez-Vazquez
Maria del Mar Diaz-Castela
Paula Morales-Hidalgo
Maria Rivera
Jill Ehrenreich-May
Publication date: 01-12-2023
Publisher: BioMed Central
Keywords: Mood Disorders
Affective Disorder
Anxiety
Published in: Child and Adolescent Psychiatry and Mental Health / Issue 1/2023
Electronic ISSN: 1753-2000
DOI: https://doi.org/10.1186/s13034-022-00550-2

2024 ASCO Annual Meeting

Springer Medicine

RETRACTED ARTICLE: Randomized controlled trial for selective preventive transdiagnostic intervention for adolescents at risk for emotional disorders

Abstract

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2023

Do parental attachment and prosocial behavior moderate the impairment from depression symptoms in adolescents who seek mental health care?

Education as a protective factor for mental health risks among youth living in highly dangerous regions in Afghanistan

Prioritizing children’s mental health amidst Sudan’s humanitarian crisis: policy recommendations for immediate action

Differences in perceived threat and trauma in children during the COVID-19 pandemic

Correction: Children’s rights and restrictive measures during the COVID-19 pandemic: implications for politicians, mental health experts and society

Attachment disorder symptoms in foster children: development and associations with attachment security